HCW Biologics Inc.

Contributing Author

Recent Articles by HCW Biologics Inc.

Oct-22	HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor "What This Means" Segment HCWB GlobeNewswire
Oct-16	HCW Biologics to Participate in the 2025 Maxim Growth Summit HCWB GlobeNewswire
Oct-16	HCW Biologics' Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer HCWB GlobeNewswire
Sep-30	HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor "What This Means" Segment About its Proprietary T-Cell Engager Program HCWB GlobeNewswire
Sep-18	HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing HCWB GlobeNewswire
Sep-16	HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development HCWB GlobeNewswire
Sep-09	HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program HCWB GlobeNewswire
Aug-25	HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market HCWB GlobeNewswire
Aug-18	HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results HCWB GlobeNewswire
Jun-27	HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors HCWB GlobeNewswire
Jun-26	HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements HCWB GlobeNewswire
Jun-04	HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech HCWB GlobeNewswire
May-15	HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results HCWB GlobeNewswire
May-13	HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules HCWB GlobeNewswire
May-13	HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization HCWB GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.